ACOG Practice Bulletin. The use of hormonal contraception in women with coexisting medical conditions. Number 18, July 2000

Int J Gynaecol Obstet. 2001 Oct;75(1):93-106. doi: 10.1016/s0020-7292(01)00520-3.

Abstract

Although numerous studies have addressed the safety and effectiveness of hormonal contraceptive use in healthy women, data are far less complete for women with underlying medical problems or other special circumstances. Because recommendations vary widely, substantial confusion exists with respect to contraceptive guidelines for women with coexisting medical conditions or other concerns. Using available scientific evidence, this Practice Bulletin will provide information to facilitate contraceptive counseling and selection for women with coexisting medical conditions.

Publication types

  • Guideline

MeSH terms

  • Age Factors
  • Anemia, Sickle Cell / complications
  • Bone Density / drug effects
  • Breast Neoplasms / chemically induced
  • Breast Neoplasms / complications
  • Contraceptives, Oral, Hormonal / adverse effects*
  • Contraceptives, Oral, Hormonal / pharmacology
  • Contraindications
  • Diabetes Complications
  • Diabetes Mellitus / chemically induced
  • Drug Interactions
  • Female
  • Humans
  • Hyperlipidemias / chemically induced
  • Hyperlipidemias / complications
  • Hypertension / chemically induced
  • Hypertension / complications
  • Lactation / drug effects
  • Lupus Erythematosus, Systemic / complications
  • Migraine Disorders / chemically induced
  • Migraine Disorders / complications
  • Postpartum Period / drug effects
  • Risk Factors
  • Smoking
  • Thromboembolism / chemically induced
  • Thromboembolism / complications
  • Thrombophilia / chemically induced
  • Thrombophilia / complications

Substances

  • Contraceptives, Oral, Hormonal